Cite

HARVARD Citation

    Khullar, V. et al. (n.d.). Patient‐reported outcomes with the β3‐adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder. Neurourology and urodynamics. 35 (8), pp. 987-994. [Online]. 
  
Back to record